Imamura, K., Nagahashi, A., Okusa, A., Sakasai, T., Tsukita, K., Kutoku, Y., . . . Inoue, H. iPSC screening identifies CACNA2D2 as a potential therapeutic target for FTLD-Tau. Elsevier.
Chicago Style (17th ed.) CitationImamura, Keiko, et al. IPSC Screening Identifies CACNA2D2 as a Potential Therapeutic Target for FTLD-Tau. Elsevier.
MLA (9th ed.) CitationImamura, Keiko, et al. IPSC Screening Identifies CACNA2D2 as a Potential Therapeutic Target for FTLD-Tau. Elsevier.
Warning: These citations may not always be 100% accurate.